Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Haller

Showing results (411-420 of 795) with videos related to

Pageof 80
Sort By:
Journal of Clinical & Translational Endocrinology|April 1, 2024
COVID-19 impacts and inequities among underserved communities with diabetesJennifer L Maizel, Michael J Haller, David M Maahs, et al.
Diabetes Care|December 20, 2023
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 DiabetesTimothy P Foster, Laura M Jacobsen, Brittany Bruggeman, et al.
Molecular Vision|January 5, 2000
North Carolina macular dystrophy (MCDR1) locus: a fine resolution genetic map and haplotype analysisK W Small, N Udar, S Yelchits, et al.
Diabetes|January 9, 2021
Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes DiagnosisMacKenzie D Williams, Rhonda Bacher, Daniel J Perry, et al.
Diabetologia|October 10, 2017
Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study childrenHelena Elding Larsson, Kristian F Lynch, Maria Lönnrot, et al.
Diabetes|January 14, 2021
Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas SizeJames J Ross, Clive H Wasserfall, Rhonda Bacher, et al.
Diabetes Technology & Therapeutics|February 5, 2026
Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension StudyRoy W Beck, Lauren Kanapka, Roshanak Monzavi, et al.
Diabetologia|October 28, 2016
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entityEzio Bonifacio, Chantal Mathieu, Gerald T Nepom, et al.
The Journal of Clinical Investigation|December 16, 2014
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetesMichael J Haller, Stephen E Gitelman, Peter A Gottlieb, et al.
Journal of Diabetes and Its Complications|July 8, 2019
Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic networkJanet B McGill, Mengdi Wu, Rodica Pop-Busui, et al.
Pageof 80

Showing results (411-420 of 795) with videos related to

Sort By:
Pageof 80
Journal of Clinical & Translational Endocrinology|April 1, 2024
COVID-19 impacts and inequities among underserved communities with diabetesJennifer L Maizel, Michael J Haller, David M Maahs, et al.
Diabetes Care|December 20, 2023
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 DiabetesTimothy P Foster, Laura M Jacobsen, Brittany Bruggeman, et al.
Molecular Vision|January 5, 2000
North Carolina macular dystrophy (MCDR1) locus: a fine resolution genetic map and haplotype analysisK W Small, N Udar, S Yelchits, et al.
Diabetes|January 9, 2021
Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes DiagnosisMacKenzie D Williams, Rhonda Bacher, Daniel J Perry, et al.
Diabetologia|October 10, 2017
Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study childrenHelena Elding Larsson, Kristian F Lynch, Maria Lönnrot, et al.
Diabetes|January 14, 2021
Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas SizeJames J Ross, Clive H Wasserfall, Rhonda Bacher, et al.
Diabetes Technology & Therapeutics|February 5, 2026
Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension StudyRoy W Beck, Lauren Kanapka, Roshanak Monzavi, et al.
Diabetologia|October 28, 2016
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entityEzio Bonifacio, Chantal Mathieu, Gerald T Nepom, et al.
The Journal of Clinical Investigation|December 16, 2014
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetesMichael J Haller, Stephen E Gitelman, Peter A Gottlieb, et al.
Journal of Diabetes and Its Complications|July 8, 2019
Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic networkJanet B McGill, Mengdi Wu, Rodica Pop-Busui, et al.
Pageof 80